John Ruckdeschel
American oncologist
John Ruckdeschel's AcademicInfluence.com Rankings


Download Badge
Medical Philosophy
Why Is John Ruckdeschel Influential?
(Suggest an Edit or Addition)According to Wikipedia, John C. Ruckdeschel is an American oncologist who has written 160 peer reviewed articles. He obtained his bachelor's degree from the Rensselaer Polytechnic Institute and later on got his medical degree from Albany Medical College. He received training at Johns Hopkins University and Beth Israel Hospital where he was a resident. He was a fellow of the National Cancer Institute and a decade later became faculty member of the second alma mater. In 1991 he became the director and CEO of Moffitt Cancer Center in Tampa where he worked with Terrance Albrecht. and ten years later held the same position at the Karmanos Cancer Institute in Detroit, Michigan. In 2009, he tried to do the same thing at the Nevada Cancer Institute and three years later became medical director at the Intermountain Healthcare in Salt Lake City. During the same years he was a chairman of both Eastern Cooperative Oncology Group and the executive officer of the Lung Cancer Study Group.
John Ruckdeschel's Published Works
Published Works
- Information and decision-making preferences of hospitalized adult cancer patients. (1988) (522)
- Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). (2007) (424)
- A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. (1994) (290)
- The multidimensional nature of cancer-related pain (1983) (285)
- Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. (2002) (208)
- Influence of clinical communication on patients' decision making on participation in clinical trials. (2008) (204)
- Physician behaviors, patient perceptions, and patient characteristics as predictors of satisfaction of hospitalized adult cancer patients (1990) (194)
- Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers (2013) (186)
- The crisis of cancer: psychological impact on family caregivers. (1997) (167)
- Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. (1997) (167)
- Strategic physician communication and oncology clinical trials. (1999) (156)
- Discussing bad news in the outpatient oncology clinic: rethinking current communication guidelines. (2006) (141)
- Information seeking during "bad news" oncology interactions: Question asking by patients and their companions. (2006) (134)
- Cancer-related pain—II. Assessment with visual analogue scales (1984) (128)
- Early diagnosis of spinal epidural metastases. (1981) (124)
- Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. (2006) (115)
- Treatment of stage IIIA non-small cell lung cancer. (2003) (114)
- The Role of Social Support in Adaptation to Cancer and to Survival (1995) (100)
- The impact of family presence on the physician-cancer patient interaction. (1991) (99)
- Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for Hodgkin's disease (1975) (97)
- Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. (2005) (89)
- Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. (1994) (89)
- Camera-Related Behaviors during Video Recorded Medical Interactions (2007) (81)
- The impact of oncologists' behaviors on patient satisfaction with morning rounds (1986) (78)
- Radiation-related pericarditis. (1975) (75)
- Cancer-related pain--I. Prevalence in an outpatient setting as a function of stage of disease and type of cancer. (1984) (75)
- Lung cancer. Practice organization. (2003) (68)
- Quality of life in lung cancer surgical adjuvant trials. (1994) (67)
- RADIATION-RELATED PERICARDIAL EFFUSIONS IN PATIENTS WITH HODGKIN'S DISEASE (1975) (66)
- Interactions between oncologists and patients during rounds. (1983) (66)
- Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women (2009) (56)
- The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group. (1994) (55)
- Oncologists' recommendations of clinical trial participation to patients. (2008) (54)
- Social Supports and Breast Cancer (1991) (50)
- Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881. (1994) (50)
- Parents' Empathic Responses and Pain and Distress in Pediatric Patients (2008) (47)
- Communication and consumer decision making about cancer clinical trials. (2003) (46)
- Community-Level Social Support Responses in a Slow-Motion Technological Disaster: The Case of Libby, Montana (2010) (43)
- A portable, unobtrusive device for videorecording clinical interactions (2005) (40)
- The Outcome of Medical Intensive Care for Lung Cancer Patients: The Case for Optimism (2011) (38)
- Management of malignant pleural effusion: an overview. (1988) (37)
- Small-cell lung cancer. (2001) (37)
- Parents’ Interpersonal Distance and Touch Behavior and Child Pain and Distress during Painful Pediatric Oncology Procedures (2007) (37)
- Attitudes toward cancer: I. The impact of a comprehensive oncology course on second‐year medical students (1981) (37)
- Bleomycin and tetracycline in malignant pleural effusions: a review. (1992) (35)
- Prevalence and correlates of posttreatment and anticipatory nausea and vomiting in cancer chemotherapy. (1986) (35)
- Studying the Process of Clinical Communication: Issues of Context, Concepts, and Research Directions (2009) (34)
- Attitudes towards cancer. II: A comparative analysis of cancer patients, medical students, medical residents, physicians and cancer educators (1982) (33)
- Management of malignant pleural effusions. (1995) (32)
- Combined modality therapy of non-small cell lung cancer. (1997) (29)
- The roles of patients' internet use for cancer information and socioeconomic status in oncologist-patient communication. (2007) (26)
- Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. (1995) (25)
- Differences in Audiotaped Versus Videotaped Physician-Patient Interactions (2002) (24)
- The influence of patient expectations regarding cure on treatment decisions. (2009) (21)
- Communication, accrual to clinical trials, and the physician-patient relationship: implications for training programs. (2009) (21)
- Real-Time Patient Satisfaction Survey and Improvement Process (2004) (20)
- Communication and informed consent (2005) (20)
- Early detection and treatment of spinal cord compression. (2005) (20)
- Understanding patient decisions about clinical trials and the associated communication process: a preliminary report. (2003) (19)
- Psychosocial oncology research. Where we have been, where we are going, and why we will not get there (1994) (19)
- Impact of Clinical Trials on the Cost of Cancer Care (2001) (17)
- Prospective trial evaluating immunocytochemical‐based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage (1993) (16)
- Methotrexate does not interfere with an appetitive Pavlovian conditioning task in Sprague-Dawley rats (1995) (15)
- N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines. (1992) (14)
- Cancer-related pain. II. Assessment with visual analogue scales J. psychosom. Res., 28 (1984) 121–124 (1985) (12)
- Social environment and social support (1991) (12)
- Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
- Initial Outcomes of a Lung Cancer Screening Program in an Integrated Community Health System. (2016) (9)
- Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer? (1998) (9)
- The future role of carboplatin. (1994) (9)
- Pulmonary metastasis of basal cell carcinoma: a rare manifestation of a common disease with variable clinical course. (2009) (8)
- Communicating with relatives/companions about cancer care (2011) (7)
- Preoperative chemotherapy for locally advanced non-small cell lung cancer. (1993) (7)
- Psychosocial aspects of cancer in adults: implications for teaching medical students. (1986) (7)
- The role of standard-dose etoposide in the management of non-small cell lung cancer. (1992) (7)
- The impact of a designated cancer unit on house staff behaviors toward patients (1987) (6)
- Why evidence-based oncology? (2000) (6)
- Fibrinogen catabolism in rats fed thrombogenic diets. (1972) (5)
- A Typology of Communication Dynamics in Families Living a Slow-Motion Technological Disaster (2012) (4)
- Preparation and antitumor activity of an N-methylcarbamate derivative of amsacrine (1993) (4)
- Social environment and social support. (1991) (4)
- Clinical Practice Guidelines ( 2 nd Edition ) Cancer-Stage IIIA : ACCP Evidence-Based Treatment of Non-small Cell Lung (2007) (4)
- The use of human lung cancer cell lines for in vitro chemosensitivity testing (1985) (4)
- 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) (1997) (4)
- Understanding treatment benefits and harms (2000) (4)
- Comment on “Treatment of Non-small Cell Lung Cancer Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)”: Response (2008) (4)
- Respiratory infections in patients with cancer (2003) (4)
- Future directions in non-small-cell lung cancer: a continuing perspective. (1998) (4)
- Future directions in non-small cell lung cancer. A personal view. (1995) (3)
- Future directions in the management of non-small cell lung cancer: A continuing perspective (1997) (3)
- In Vitro Characterization of Non-Small Cell Lung Cancer (1986) (3)
- The influence of patient and companion cure expectations on treatment decisions (2008) (3)
- Patient attributes and information provided about clinical trials (2007) (3)
- Gefitinib and celecoxib in patients with platinum refractory non-small cell lung cancer (NSCLC). (2004) (3)
- Second-line chemotherapy for non-small cell lung cancer. (2006) (3)
- Randomized phase II evaluation of preoperative radiation therapy (XRT) and chemotherapy with mitomycin-C, vinblastine, and cisplatin (MVP) for patients with pathologic stage IIIA and IIIB non-small cell lung cancer (NSCLC) (1990) (2)
- The cost of success in the treatment of thoracic malignancies: Commentary (1995) (2)
- Patient and treatment factors in the development of chemotherapy-related nausea and vomiting (1981) (2)
- Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy (2020) (2)
- A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations (2007) (2)
- Economic analysis of cancer treatment costs: another tool for oncology managers. (2001) (2)
- Unconventional style reaps rewards for Ruckdeschel. Physician executive's career carries cancer center to the forefront. Interview by Patty Ryan. (2001) (2)
- Cellular characterization of lung cancer. A caveat. (1993) (2)
- Amantadine and pulmonary peripheral airways. (1977) (2)
- Question asking by black and white patients and companions during clinical trial offers (2007) (1)
- Transdisciplinary studies of surgical oncology trial accrual (2006) (1)
- Gefitinib and celecoxib in patients with platinum refractory non-small cell lung cancer (NSCLC) (2004) (1)
- A comparative overview of non-small cell lung cancer: 1980 versus 1991 (1993) (1)
- Introduction: LCSG—The Final Analysis (1994) (1)
- Special problems in the older cancer patient: spinal cord compression and pleural effusions. (1992) (1)
- Critical factors for patient management. (2003) (1)
- A phase III trial-in-progress called REPLATINUM that compares RRx-001 + a platinum doublet to a platinum doublet in third-line or beyond small cell lung cancer. (2020) (1)
- The problem of cancer: lung cancer as a paradigm--keynote address summary. (2005) (1)
- Malignant Effusions in the Chest (2001) (0)
- Surgical complications causing dyspnea in cancer patients (2003) (0)
- How do interventions for the management of malignant pleural effusions compare? (2019) (0)
- UC Davis UC Davis Previously Published Works Title Hybrid Control Network Intrusion Detection Systems for Automated Power Distribution Systems (2007) (0)
- Slow but real progress in the treatment of thoracic malignancies. (1998) (0)
- Attempts to enhance locoregional control of cancer by radiotherapy, phototherapy, and combined modality therapy. (1989) (0)
- CONTROVERSY OVER FOR MALIGNANT PLEURAL EFFUSIONS (1994) (0)
- We have met the enemy... and they is us (1996) (0)
- A Cancer Center and Research Institute at the University of Mississippi Medical Center. (2020) (0)
- Lung and mediastinum. (1997) (0)
- Controversy over sclerotherapy for malignant pleural effusions. (1994) (0)
- Preparation and Antitumor Activity of an N‐Methylcarbamate Derivative of Amsacrine. (1994) (0)
- Lung and mediastinum. (1997) (0)
- Preoperative paclitaxel plus carboplatin for patients with intermediate-risk non-small cell lung cancer. (1996) (0)
- Strategic P hysician C ommunication a nd O ncology Clinical T rials (1999) (0)
- The inadequacy of cardiovascular safety reporting in breast cancer clinical trials. (2020) (0)
- What are the benefits and harms of screening for lung cancer (2017) (0)
- Letter: Tumor registry. (1973) (0)
- Granulomatous solitary pulmonary nodule. (2011) (0)
- This house believes that non-surgical treatment is standard treatment in the management of patients withclinical N2 non-small lung cancer (1994) (0)
- Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials (2022) (0)
- 826 Spinal cord compression in lung cancer. MRI as the first diagnostic test is more cost effective (1997) (0)
- EP01.06-004 Eliciting Quantitative Smoking History by the Use of Natural Language Processing (2022) (0)
- Does E-Commerce Belong in a Cancer and Research Institution? (2000) (0)
- Dr. Mardiney and Dr. Ruckdeschel's reply (1977) (0)
This paper list is powered by the following services:
Other Resources About John Ruckdeschel
What Schools Are Affiliated With John Ruckdeschel?
John Ruckdeschel is affiliated with the following schools: